MARCIA BLEREAU: Open Payments
NPI 1588198212 · MORGAN CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 14 payments from 8 companies in 2025. Trend: 2023 $188 · 2024 $325 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $86 |
| Corium, LLC | 5 | $65 |
| ABBVIE INC. | 3 | $59 |
| Verona Pharma, Inc. | 1 | $26 |
| PFIZER INC. | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Auvelity, UPTRAVI, Azstarys, QULIPTA, Ohtuvayre, PREVNAR 20, VRAYLAR, CAPLYTA.
Industry payments across LA — which companies pay providers there.
